{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:03:20Z","timestamp":1792843400466,"version":"4.5.0"},"reference-count":45,"publisher":"National Academy of Sciences","issue":"40","content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2014,10,7]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>Antibiotic resistance is a growing threat, but the pace of drug discovery remains slow. Combination therapy can inhibit the emergence of de novo resistance but is often too toxic for long-term use. Alternating treatments, in which drugs are used sequentially with periodic switching, have been proposed as a substitute, but it remains uncertain when and how they slow the evolution of resistance. Using experimental evolution and whole-genome sequencing, we find that alternating drugs slows the rate of increase in resistance compared with single-drug treatments, by constraining resistance mutations with trade-offs in resistance to a second drug. Thus, drug combinations can exploit these trade-offs to slow the evolution of resistance, even when the drugs are not used simultaneously.<\/jats:p>","DOI":"10.1073\/pnas.1409800111","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T03:21:36Z","timestamp":1411442496000},"page":"14494-14499","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":259,"title":["Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance"],"prefix":"10.1073","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5559-5289","authenticated-orcid":false,"given":"Seungsoo","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Systems Biology, Harvard Medical School, Boston, MA 02115; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tami D.","family":"Lieberman","sequence":"additional","affiliation":[{"name":"Department of Systems Biology, Harvard Medical School, Boston, MA 02115; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Kishony","sequence":"additional","affiliation":[{"name":"Department of Systems Biology, Harvard Medical School, Boston, MA 02115; and"},{"name":"Faculty of Biology, Technion \u2013 Israel Institute of Technology, Technion City, Haifa 3200003, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2014,9,22]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.321.5887.356","article-title":"The bacteria fight back","volume":"321","author":"Taubes G","year":"2008","unstructured":"G Taubes, The bacteria fight back. Science 321, 356\u2013361 (2008).","journal-title":"Science"},{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1038\/nm1145","article-title":"Antibacterial resistance worldwide: Causes, challenges and responses","volume":"10","author":"Levy SB","year":"2004","unstructured":"SB Levy, B Marshall, Antibacterial resistance worldwide: Causes, challenges and responses. Nat Med 10, S122\u2013S129 (2004).","journal-title":"Nat Med"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1073\/pnas.97.4.1938","article-title":"The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions","volume":"97","author":"Lipsitch M","year":"2000","unstructured":"M Lipsitch, CT Bergstrom, BR Levin, The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions. Proc Natl Acad Sci USA 97, 1938\u20131943 (2000).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_4_2","volume-title":"Antibiotic Resistance Threats in the United States 2013","author":"US Department of Health and Human Services","year":"2013","unstructured":"; US Department of Health and Human Services Antibiotic Resistance Threats in the United States 2013 (Centers for Disease Control and Prevention, Atlanta, 2013)."},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/ng.997","article-title":"Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes","volume":"43","author":"Lieberman TD","year":"2011","unstructured":"TD Lieberman, , Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat Genet 43, 1275\u20131280 (2011).","journal-title":"Nat Genet"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM200202213460820","article-title":"Emergence of macrolide resistance during treatment of pneumococcal pneumonia","volume":"346","author":"Musher DM","year":"2002","unstructured":"DM Musher, , Emergence of macrolide resistance during treatment of pneumococcal pneumonia. N Engl J Med 346, 630\u2013631 (2002).","journal-title":"N Engl J Med"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/AAC.41.2.363","article-title":"The population dynamics of antimicrobial chemotherapy","volume":"41","author":"Lipsitch M","year":"1997","unstructured":"M Lipsitch, BR Levin, The population dynamics of antimicrobial chemotherapy. Antimicrob Agents Chemother 41, 363\u2013373 (1997).","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/jac\/dkr337","article-title":"Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-\u03b2-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis","volume":"66","author":"Stone NR","year":"2011","unstructured":"NR Stone, , Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-\u03b2-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis. J Antimicrob Chemother 66, 2677\u20132678 (2011).","journal-title":"J Antimicrob Chemother"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nrmicro2693","article-title":"Tackling antibiotic resistance","volume":"9","author":"Bush K","year":"2011","unstructured":"K Bush, , Tackling antibiotic resistance. Nat Rev Microbiol 9, 894\u2013896 (2011).","journal-title":"Nat Rev Microbiol"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/0970-2113.83977","article-title":"Tuberculosis chemotherapy in the 21 century: Back to the basics","volume":"28","author":"Joshi JM","year":"2011","unstructured":"JM Joshi, Tuberculosis chemotherapy in the 21 century: Back to the basics. Lung India 28, 193\u2013200 (2011).","journal-title":"Lung India"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1007\/BF02561666","article-title":"Combination therapy as a tool to prevent emergence of bacterial resistance","volume":"27","author":"Mouton JW","year":"1999","unstructured":"JW Mouton, Combination therapy as a tool to prevent emergence of bacterial resistance. Infection 27, S24\u2013S28 (1999).","journal-title":"Infection"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"14918","DOI":"10.1073\/pnas.0800944105","article-title":"Drug interactions modulate the potential for evolution of resistance","volume":"105","author":"Michel JB","year":"2008","unstructured":"JB Michel, PJ Yeh, R Chait, Jr RC Moellering, R Kishony, Drug interactions modulate the potential for evolution of resistance. Proc Natl Acad Sci USA 105, 14918\u201314923 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"13977","DOI":"10.1073\/pnas.0805965105","article-title":"Accelerated evolution of resistance in multidrug environments","volume":"105","author":"Hegreness M","year":"2008","unstructured":"M Hegreness, N Shoresh, D Damian, D Hartl, R Kishony, Accelerated evolution of resistance in multidrug environments. Proc Natl Acad Sci USA 105, 13977\u201313981 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1515\/znc-1990-0528","article-title":"Negative cross resistance; a possible key to atrazine resistance management: A cell for whole plant data","volume":"45","author":"Gressel J","year":"1990","unstructured":"J Gressel, L Segel, Negative cross resistance; a possible key to atrazine resistance management: A cell for whole plant data. Z Naturforsch C 45, 470\u2013473 (1990).","journal-title":"Z Naturforsch C"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1128\/AAC.26.6.797","article-title":"Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes","volume":"26","author":"Sanders CC","year":"1984","unstructured":"CC Sanders, Jr WE Sanders, RV Goering, V Werner, Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes. Antimicrob Agents Chemother 26, 797\u2013801 (1984).","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"ra132","DOI":"10.1126\/scitranslmed.3006609","article-title":"Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development","volume":"5","author":"Imamovic L","year":"2013","unstructured":"L Imamovic, MOA Sommer, Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci Transl Med 5, ra132 (2013).","journal-title":"Sci Transl Med"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nrmicro2133","article-title":"Drug interactions and the evolution of antibiotic resistance","volume":"7","author":"Yeh PJ","year":"2009","unstructured":"PJ Yeh, MJ Hegreness, AP Aiden, R Kishony, Drug interactions and the evolution of antibiotic resistance. Nat Rev Microbiol 7, 460\u2013466 (2009).","journal-title":"Nat Rev Microbiol"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0025-7125(05)70294-7","article-title":"Antibiotic synergy and antagonism","volume":"84","author":"Acar JF","year":"2000","unstructured":"JF Acar, Antibiotic synergy and antagonism. Med Clin North Am 84, 1391\u20131406 (2000).","journal-title":"Med Clin North Am"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with Gram-negative bacteria","volume":"25","author":"Tamma PD","year":"2012","unstructured":"PD Tamma, SE Cosgrove, LL Maragakis, Combination therapy for treatment of infections with Gram-negative bacteria. Clin Microbiol Rev 25, 450\u2013470 (2012).","journal-title":"Clin Microbiol Rev"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(04)01108-9","article-title":"Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis","volume":"4","author":"Safdar N","year":"2004","unstructured":"N Safdar, J Handelsman, DG Maki, Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 4, 519\u2013527 (2004).","journal-title":"Lancet Infect Dis"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: A commentary","volume":"11","author":"Chow JW","year":"1999","unstructured":"JW Chow, VL Yu, Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: A commentary. Int J Antimicrob Agents 11, 7\u201312 (1999).","journal-title":"Int J Antimicrob Agents"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.2010.05867.x","article-title":"Antibiotic heterogeneity: From concept to practice","volume":"1213","author":"Bal AM","year":"2010","unstructured":"AM Bal, A Kumar, IM Gould, Antibiotic heterogeneity: From concept to practice. Ann N Y Acad Sci 1213, 81\u201391 (2010).","journal-title":"Ann N Y Acad Sci"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3934\/mbe.2010.7.923","article-title":"Antibiotic cycling versus mixing: The difficulty of using mathematical models to definitively quantify their relative merits","volume":"7","author":"Beardmore RE","year":"2010","unstructured":"RE Beardmore, R Pena-Miller, Antibiotic cycling versus mixing: The difficulty of using mathematical models to definitively quantify their relative merits. Math Biosci Eng 7, 923\u2013933 (2010).","journal-title":"Math Biosci Eng"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jac\/dkh482","article-title":"Antibiotic cycling or rotation: A systematic review of the evidence of efficacy","volume":"55","author":"Brown EM","year":"2005","unstructured":"EM Brown, D Nathwani, Antibiotic cycling or rotation: A systematic review of the evidence of efficacy. J Antimicrob Chemother 55, 6\u20139 (2005).","journal-title":"J Antimicrob Chemother"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"13285","DOI":"10.1073\/pnas.0402298101","article-title":"Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals","volume":"101","author":"Bergstrom CT","year":"2004","unstructured":"CT Bergstrom, M Lo, M Lipsitch, Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci USA 101, 13285\u201313290 (2004).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1073\/pnas.94.22.12106","article-title":"Evaluating treatment protocols to prevent antibiotic resistance","volume":"94","author":"Bonhoeffer S","year":"1997","unstructured":"S Bonhoeffer, M Lipsitch, BR Levin, Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci USA 94, 12106\u201312111 (1997).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ng.1034","article-title":"Evolutionary paths to antibiotic resistance under dynamically sustained drug selection","volume":"44","author":"Toprak E","year":"2012","unstructured":"E Toprak, , Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet 44, 101\u2013105 (2012).","journal-title":"Nat Genet"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/AAC.39.2.279","article-title":"Trimethoprim and sulfonamide resistance","volume":"39","author":"Huovinen P","year":"1995","unstructured":"P Huovinen, L Sundstr\u00f6m, G Swedberg, O Sk\u00f6ld, Trimethoprim and sulfonamide resistance. Antimicrob Agents Chemother 39, 279\u2013289 (1995).","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/jmbi.1997.1552","article-title":"Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA","volume":"277","author":"Fourmy D","year":"1998","unstructured":"D Fourmy, MI Recht, JD Puglisi, Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA. J Mol Biol 277, 347\u2013362 (1998).","journal-title":"J Mol Biol"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","DOI":"10.1128\/9781555817886","volume-title":"Antibiotics: Actions, Origins, Resistance","author":"Walsh C","year":"2003","unstructured":"C Walsh Antibiotics: Actions, Origins, Resistance (ASM, Washington, DC, 2003)."},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy FD","year":"1998","unstructured":"FD Lowy, Staphylococcus aureus infections. N Engl J Med 339, 520\u2013532 (1998).","journal-title":"N Engl J Med"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1128\/AAC.34.11.2050","article-title":"Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital","volume":"34","author":"Raviglione MC","year":"1990","unstructured":"MC Raviglione, , Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital. Antimicrob Agents Chemother 34, 2050\u20132054 (1990).","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1179\/joc.2009.21.2.115","article-title":"Trimethoprim-sulfamethoxazole for methicillin-resistant Staphylococcus aureus: A forgotten alternative?","volume":"21","author":"Pappas G","year":"2009","unstructured":"G Pappas, AP Athanasoulia, DK Matthaiou, ME Falagas, Trimethoprim-sulfamethoxazole for methicillin-resistant Staphylococcus aureus: A forgotten alternative? J Chemother 21, 115\u2013126 (2009).","journal-title":"J Chemother"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/JCM.36.5.1220-1225.1998","article-title":"Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene","volume":"36","author":"Suzuki Y","year":"1998","unstructured":"Y Suzuki, , Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. J Clin Microbiol 36, 1220\u20131225 (1998).","journal-title":"J Clin Microbiol"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/428052","article-title":"Mechanisms of resistance to quinolones","volume":"41","author":"Jacoby GA","year":"2005","unstructured":"GA Jacoby, Mechanisms of resistance to quinolones. Clin Infect Dis 41, S120\u2013S126 (2005).","journal-title":"Clin Infect Dis"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/JB.181.9.2846-2851.1999","article-title":"The Staphylococcus aureus rsbW (orf159) gene encodes an anti-sigma factor of SigB","volume":"181","author":"Miyazaki E","year":"1999","unstructured":"E Miyazaki, JM Chen, C Ko, WR Bishai, The Staphylococcus aureus rsbW (orf159) gene encodes an anti-sigma factor of SigB. J Bacteriol 181, 2846\u20132851 (1999).","journal-title":"J Bacteriol"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1128\/JB.182.11.3259-3265.2000","article-title":"The clp proteases of Bacillus subtilis are directly involved in degradation of misfolded proteins","volume":"182","author":"Kr\u00fcger E","year":"2000","unstructured":"E Kr\u00fcger, E Witt, S Ohlmeier, R Hanschke, M Hecker, The clp proteases of Bacillus subtilis are directly involved in degradation of misfolded proteins. J Bacteriol 182, 3259\u20133265 (2000).","journal-title":"J Bacteriol"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/msb.2013.57","article-title":"Bacterial evolution of antibiotic hypersensitivity","volume":"9","author":"L\u00e1z\u00e1r V","year":"2013","unstructured":"V L\u00e1z\u00e1r, , Bacterial evolution of antibiotic hypersensitivity. Mol Syst Biol 9, 700 (2013).","journal-title":"Mol Syst Biol"},{"key":"e_1_3_4_39_2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/jb.64.4.489-499.1952","article-title":"Genetic studies on microbial cross resistance to toxic agents. I. Cross resistance of Escherichia coli to fifteen antibiotics","volume":"64","author":"Szybalski W","year":"1952","unstructured":"W Szybalski, V Bryson, Genetic studies on microbial cross resistance to toxic agents. I. Cross resistance of Escherichia coli to fifteen antibiotics. J Bacteriol 64, 489\u2013499 (1952).","journal-title":"J Bacteriol"},{"key":"e_1_3_4_40_2","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/molbev\/msu191","article-title":"Strength of selection pressure is an important parameter contributing to the complexity of antibiotic resistance evolution","volume":"31","author":"Oz T","year":"2014","unstructured":"T Oz, , Strength of selection pressure is an important parameter contributing to the complexity of antibiotic resistance evolution. Mol Biol Evol 31, 2387\u20132401 (2014).","journal-title":"Mol Biol Evol"},{"key":"e_1_3_4_41_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/science.1123539","article-title":"Darwinian evolution can follow only very few mutational paths to fitter proteins","volume":"312","author":"Weinreich DM","year":"2006","unstructured":"DM Weinreich, NF Delaney, MA Depristo, DL Hartl, Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312, 111\u2013114 (2006).","journal-title":"Science"},{"key":"e_1_3_4_42_2","doi-asserted-by":"crossref","first-page":"e1000578","DOI":"10.1371\/journal.pgen.1000578","article-title":"Positive epistasis drives the acquisition of multidrug resistance","volume":"5","author":"Trindade S","year":"2009","unstructured":"S Trindade, , Positive epistasis drives the acquisition of multidrug resistance. PLoS Genet 5, e1000578 (2009).","journal-title":"PLoS Genet"},{"key":"e_1_3_4_43_2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/jac\/32.4.519","article-title":"The post-antibiotic effect","volume":"32","author":"MacKenzie FM","year":"1993","unstructured":"FM MacKenzie, IM Gould, The post-antibiotic effect. J Antimicrob Chemother 32, 519\u2013537 (1993).","journal-title":"J Antimicrob Chemother"},{"key":"e_1_3_4_44_2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/jac\/dki191","article-title":"Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates","volume":"56","author":"Gillespie SH","year":"2005","unstructured":"SH Gillespie, S Basu, AL Dickens, DM O\u2019Sullivan, TD McHugh, Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates. J Antimicrob Chemother 56, 344\u2013348 (2005).","journal-title":"J Antimicrob Chemother"},{"key":"e_1_3_4_45_2","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1128\/JB.00027-11","article-title":"Whole-genome sequencing of Staphylococcus aureus strain RN4220, a key laboratory strain used in virulence research, identifies mutations that affect not only virulence factors but also the fitness of the strain","volume":"193","author":"Nair D","year":"2011","unstructured":"D Nair, , Whole-genome sequencing of Staphylococcus aureus strain RN4220, a key laboratory strain used in virulence research, identifies mutations that affect not only virulence factors but also the fitness of the strain. J Bacteriol 193, 2332\u20132335 (2011).","journal-title":"J Bacteriol"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1409800111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T07:42:04Z","timestamp":1654587724000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1409800111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,22]]},"references-count":45,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2014,10,7]]}},"alternative-id":["10.1073\/pnas.1409800111"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1409800111","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,22]]},"assertion":[{"value":"2014-09-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}